questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Antirhumatismaux
Antirhumatismaux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Maladies rhumatismales
Diagnostic médical
Tests diagnostiques
Imagerie par résonance magnétique
Symptômes
Douleur articulaire
Protéine C-réactive
Inflammation
Évaluation de la douleur
Fonctionnalité
Symptômes
5
Variabilité des symptômes
Patients
Complications
Évolution de la maladie
Prévention
5
Prévention
Exercice physique
Tabagisme
Facteurs de risque
Activité physique
Mobilité
Alimentation
Antioxydants
Stress
Gestion de la douleur
Traitements
5
Médecine personnalisée
Traitement
Effets secondaires
Infections
Suivi médical
Ajustement du traitement
Complications
5
Complications
Dommages articulaires
Signes cliniques
Infection
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Facteurs environnementaux
Produits chimiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antirhumatismaux : Questions médicales les plus fréquentes",
"headline": "Antirhumatismaux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antirhumatismaux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-11-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antirhumatismaux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Utilisations thérapeutiques",
"url": "https://questionsmedicales.fr/mesh/D045506",
"about": {
"@type": "MedicalCondition",
"name": "Utilisations thérapeutiques",
"code": {
"@type": "MedicalCode",
"code": "D045506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anti-inflammatoires non stéroïdiens",
"alternateName": "Anti-Inflammatory Agents, Non-Steroidal",
"url": "https://questionsmedicales.fr/mesh/D000894",
"about": {
"@type": "MedicalCondition",
"name": "Anti-inflammatoires non stéroïdiens",
"code": {
"@type": "MedicalCode",
"code": "D000894",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.329.030"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs des cyclooxygénases",
"alternateName": "Cyclooxygenase Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D016861",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs des cyclooxygénases",
"code": {
"@type": "MedicalCode",
"code": "D016861",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.329.030.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la cyclooxygénase 2",
"alternateName": "Cyclooxygenase 2 Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D052246",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la cyclooxygénase 2",
"code": {
"@type": "MedicalCode",
"code": "D052246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.329.030.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la cyclooxygénase 2",
"alternateName": "Cyclooxygenase 2 Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D052246",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la cyclooxygénase 2",
"code": {
"@type": "MedicalCode",
"code": "D052246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.329.030.500.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Antigoutteux",
"alternateName": "Gout Suppressants",
"url": "https://questionsmedicales.fr/mesh/D006074",
"about": {
"@type": "MedicalCondition",
"name": "Antigoutteux",
"code": {
"@type": "MedicalCode",
"code": "D006074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.329.337"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Uricosuriques",
"alternateName": "Uricosuric Agents",
"url": "https://questionsmedicales.fr/mesh/D014528",
"about": {
"@type": "MedicalCondition",
"name": "Uricosuriques",
"code": {
"@type": "MedicalCode",
"code": "D014528",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.329.337.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Antirhumatismaux",
"alternateName": "Antirheumatic Agents",
"code": {
"@type": "MedicalCode",
"code": "D018501",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Morten Wang Fagerland",
"url": "https://questionsmedicales.fr/author/Morten%20Wang%20Fagerland",
"affiliation": {
"@type": "Organization",
"name": "Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway."
}
},
{
"@type": "Person",
"name": "Ivana Hollan",
"url": "https://questionsmedicales.fr/author/Ivana%20Hollan",
"affiliation": {
"@type": "Organization",
"name": "Beitostølen Health and Sport Centre, Beitostølen, Norway."
}
},
{
"@type": "Person",
"name": "Gunnbjørg Hjeltnes",
"url": "https://questionsmedicales.fr/author/Gunnbj%C3%B8rg%20Hjeltnes",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Innlandet Hospital Trust, Lillehammer, Norway."
}
},
{
"@type": "Person",
"name": "Stefan Agewall",
"url": "https://questionsmedicales.fr/author/Stefan%20Agewall",
"affiliation": {
"@type": "Organization",
"name": "University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, Oslo, Norway."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Rheumatoid meningitis: a rare neurological complication of rheumatoid arthritis.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37350975",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1065650"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rheumatoid meningitis in the absence of rheumatoid arthritis: 2 cases.",
"datePublished": "2024-07-15",
"url": "https://questionsmedicales.fr/article/39009960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12883-024-03751-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lipid metabolism and rheumatoid arthritis.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37325667",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1190607"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of epigenetics on rheumatoid arthritis.",
"datePublished": "2023-04-24",
"url": "https://questionsmedicales.fr/article/37094250",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5867/medwave.2023.03.2619"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predicting the onset of rheumatoid arthritis.",
"datePublished": "2023-02-25",
"url": "https://questionsmedicales.fr/article/36842761",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jbspin.2023.105556"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Antirhumatismaux",
"item": "https://questionsmedicales.fr/mesh/D018501"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antirhumatismaux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antirhumatismaux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antirhumatismaux",
"description": "Comment diagnostiquer une maladie rhumatismale ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels symptômes indiquent une maladie rhumatismale ?\nLes marqueurs inflammatoires sont-ils utiles ?\nComment évaluer la gravité de la maladie ?",
"url": "https://questionsmedicales.fr/mesh/D018501?mesh_terms=Arthritis,+Rheumatoid#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antirhumatismaux",
"description": "Quels sont les symptômes courants des maladies rhumatismales ?\nLa raideur matinale est-elle un symptôme clé ?\nLes symptômes varient-ils selon les patients ?\nLes symptômes peuvent-ils s'aggraver avec le temps ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D018501?mesh_terms=Arthritis,+Rheumatoid#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antirhumatismaux",
"description": "Peut-on prévenir les maladies rhumatismales ?\nLe tabagisme influence-t-il les maladies rhumatismales ?\nL'activité physique est-elle bénéfique ?\nUne alimentation anti-inflammatoire est-elle recommandée ?\nLe stress a-t-il un impact sur les symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D018501?mesh_terms=Arthritis,+Rheumatoid#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antirhumatismaux",
"description": "Quels types d'antirhumatismaux existent ?\nComment les DMARDs agissent-ils ?\nLes traitements sont-ils personnalisés ?\nQuels effets secondaires peuvent survenir ?\nLes traitements nécessitent-ils un suivi régulier ?",
"url": "https://questionsmedicales.fr/mesh/D018501?mesh_terms=Arthritis,+Rheumatoid#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antirhumatismaux",
"description": "Quelles sont les complications possibles des maladies rhumatismales ?\nLes maladies rhumatismales peuvent-elles affecter d'autres organes ?\nComment prévenir les complications ?\nLes complications peuvent-elles être réversibles ?\nQuels signes indiquent une complication ?",
"url": "https://questionsmedicales.fr/mesh/D018501?mesh_terms=Arthritis,+Rheumatoid#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antirhumatismaux",
"description": "Quels sont les principaux facteurs de risque ?\nL'obésité est-elle un facteur de risque ?\nLes infections peuvent-elles déclencher des maladies rhumatismales ?\nLe sexe influence-t-il le risque de maladie ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D018501?mesh_terms=Arthritis,+Rheumatoid#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie rhumatismale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, les antécédents médicaux et des tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang, des radiographies et parfois des IRM sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie rhumatismale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs articulaires, raideur matinale, fatigue et gonflement des articulations."
}
},
{
"@type": "Question",
"name": "Les marqueurs inflammatoires sont-ils utiles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme la protéine C-réactive aident à évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Comment évaluer la gravité de la maladie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des échelles de douleur et des tests fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies rhumatismales ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs, raideurs, gonflements et fatigue sont fréquents."
}
},
{
"@type": "Question",
"name": "La raideur matinale est-elle un symptôme clé ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la raideur matinale qui dure plus d'une heure est significative."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les patients ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils s'aggraver avec le temps ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les symptômes peuvent s'aggraver et entraîner des complications."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur et la fatigue peuvent significativement réduire la qualité de vie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies rhumatismales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures comme l'exercice régulier et une alimentation saine peuvent aider."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les maladies rhumatismales ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque qui peut aggraver les symptômes."
}
},
{
"@type": "Question",
"name": "L'activité physique est-elle bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activité physique régulière peut améliorer la mobilité et réduire la douleur."
}
},
{
"@type": "Question",
"name": "Une alimentation anti-inflammatoire est-elle recommandée ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en oméga-3 et en antioxydants peut être bénéfique."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les symptômes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et affecter la gestion de la douleur."
}
},
{
"@type": "Question",
"name": "Quels types d'antirhumatismaux existent ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe des anti-inflammatoires, des DMARDs et des biologiques."
}
},
{
"@type": "Question",
"name": "Comment les DMARDs agissent-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les DMARDs modifient la progression de la maladie et réduisent l'inflammation."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est souvent adapté en fonction des besoins individuels."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent survenir ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des nausées, des éruptions cutanées et des infections."
}
},
{
"@type": "Question",
"name": "Les traitements nécessitent-ils un suivi régulier ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour ajuster le traitement et surveiller les effets."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des maladies rhumatismales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des dommages articulaires, des maladies cardiovasculaires et des infections."
}
},
{
"@type": "Question",
"name": "Les maladies rhumatismales peuvent-elles affecter d'autres organes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent toucher le cœur, les poumons et les reins, entraînant des complications."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement précoce et un suivi régulier aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs accrues, de la fièvre ou des signes d'infection peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, des antécédents familiaux et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité augmente le risque de développer des maladies rhumatismales."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles déclencher des maladies rhumatismales ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent précipiter l'apparition de maladies rhumatismales."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de maladie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont généralement plus à risque de développer des maladies rhumatismales."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains produits chimiques peut augmenter le risque de maladies rhumatismales."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 24/11/2025
Contenu vérifié selon les dernières recommandations médicales
11 publications dans cette catégorie
Publications dans "Antirhumatismaux" :
3 publications dans cette catégorie
Affiliations :
Oslo Centre for Biostatistics and Epidemiology, Research Support Services, Oslo University Hospital, Oslo, Norway.
Publications dans "Antirhumatismaux" :
3 publications dans cette catégorie
Affiliations :
Beitostølen Health and Sport Centre, Beitostølen, Norway.
Norwegian University of Science and Technology, Gjøvik, Norway.
Publications dans "Antirhumatismaux" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Innlandet Hospital Trust, Lillehammer, Norway.
Publications dans "Antirhumatismaux" :
3 publications dans cette catégorie
Affiliations :
University of Oslo, Faculty of Medicine, Institute of Clinical Medicine, Oslo, Norway.
Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway.
Publications dans "Antirhumatismaux" :
3 publications dans cette catégorie
Affiliations :
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Division of Rheumatology, University of Washington.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Division of Rheumatology, Children's of Alabama and Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Programmbereich Epidemiologie und Versorgungsforschung, Deutsches Rheuma-Forschungszentrum Berlin, Charitéplatz 1, 10117, Berlin, Deutschland. albrecht@drfz.de.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory medicine, Innlandet Hospital Trust, Lillehammer, Norway.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Volvat Medical Center, Lillehammer, Norway.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Professor, Division of Infectious Diseases, Oregon Health and Science University, Portland, OR.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Professor, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL jrcurtis@uabmc.edu.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Vestre Viken Trust, Drammen, Norway.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine & Rheumatology, Faculty of Medicine, Gazi University, Ankara, Turkey
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology, National Taiwan University Hospital, 7 Chung Shan S Rd, Taipei, 10048, Taiwan. tftsai@yahoo.com.
Department of Dermatology, National Taiwan University Hospital & National Taiwan University College of Medicine, Taipei, Taiwan. tftsai@yahoo.com.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Northwestern Medicine, Chicago, Illinois, United States.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States.
Publications dans "Antirhumatismaux" :
2 publications dans cette catégorie
Affiliations :
George Washington University School of Medicine and Health Sciences, Washington, DC, United States.
Publications dans "Antirhumatismaux" :
To describe the clinical and neuroimaging characteristics of rheumatoid meningitis (RM) in Chinese patients....
The patients admitted to our hospital with the diagnosis of RM in the past 8 years were retrospectively analyzed....
Six patients with RM were identified among 933 patients admitted with rheumatoid arthritis (RA). The symptoms of meningitis occurred after onset of arthritis in five patients and before onset in one. ...
Chinese patients with RM share some remarkable clinical and neuroimaging features and respond well to appropriate immunotherapy. Tocilizumab could be a treatment option for this severe complication of...
Rheumatoid meningitis (RM) is a rare extra-articular manifestation of rheumatoid arthritis (RA) that has been increasingly recognized by neurologists. However, the diversity of its clinical manifestat...
As a chronic progressive autoimmune disease, rheumatoid arthritis (RA) is characterized by mainly damaging the synovium of peripheral joints and causing joint destruction and early disability. RA is a...
Rheumatoid arthritis is an autoimmune and inflammatory disease that predominantly affects the diarthrodial joints. In this pathology, environmental or behavioral factors can act in synergy with geneti...
Various scores have attempted to predict the onset of rheumatoid arthritis (RA). In particular, EULAR proposed a simple rule to identify new-onset arthralgia suspicious for progression to RA. However,...
Rheumatoid arthritis affects approximately between 0.3 and 1.2% of the world population. In Latin America, different studies have estimated a prevalence between 0.2 and 0.5% in the population over 16 ...
To identify the epidemiological profile of rheumatoid arthritis....
Descriptive cross-sectional design carried out in an urban population of a social security institution in Mexico. The information of the clinical file of 373 patients was studied. The epidemiological ...
The wrists were the most affected joints with 44.6% (95% CI: 39.5-49.6%). The extra-articular manifestation with the highest prevalence was asthenia with 9.9% (95% CI: 6.9-12.9%); predominant diagnosi...
This work has described the epidemiological profile of the patient with rheumatoid arthritis in different dimensions....
JAK (Janus kinase) is a type of non-receptor tyrosine kinase that includes JAK1, JAK2, JAK3, and Tyk2. Currently, there are five JAK inhibitors approved for treating rheumatoid arthritis. These inhibi...
This review outlines the mode of actions and the results of Phase III trials of the JAK inhibitors which have been approved for the treatment of rheumatoid arthritis....
JAK inhibitors have the potential to finely tune immunity and inflammation in patients with rheumatoid arthritis. The in vitro data indicates that IL-6 signaling is suppressed by all JAK inhibitors, w...
To study the joint distribution and clinical picture of rheumatoid arthritis (RA) at the initial presentation in seropositive (anti-citrullinated protein antibody (ACPA) and/or rheumatoid factor (RF) ...
Data of patients who received reimbursement for DMARDs for newly diagnosed RA in 1/2019 to 9/2021 were extracted from the national databases. Joint counts, presence of symmetrical swelling, other dise...
Data of 1816 ACPA and RF-tested patients were included. Symmetrical swelling was present in 75% of patients. Seronegative versus positive patients had higher value for all disease activity measures an...
Incident RA presents mainly as symmetric arthritis. Seronegative patients have higher disease burden at the initial presentation. Patients experiencing more severe pain and decreased functional abilit...
Depression is a common and disabling comorbidity in rheumatoid arthritis that not only decreases the likelihood of remission and treatment adherence but also increases the risk of disability and morta...
Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology. Due to the rise in the incidence rate of RA and the limitations of existing therapies, the search for new treatment strategies f...